Risankizumab-Rzaa is a medication that belongs to a class of drugs known as interleukin inhibitors. It is used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. This medication works by targeting a specific protein in the body that is involved in the inflammatory response that leads to psoriasis symptoms.

Risankizumab-Rzaa is administered as an injection under the skin, typically once every 12 weeks after an initial loading dose. It is important to follow the dosing schedule prescribed by your healthcare provider to ensure the best results. This medication has been shown to significantly improve symptoms of psoriasis, including reducing the redness, scaling, and thickness of plaques on the skin.

As with any medication, Risankizumab-Rzaa may cause side effects in some individuals. Common side effects may include upper respiratory infections, headache, and injection site reactions. It is important to discuss any concerns or side effects with your healthcare provider.

Before starting Risankizumab-Rzaa, it is important to inform your healthcare provider about any other medications you are taking, as well as any medical conditions you may have. This will help ensure that Risankizumab-Rzaa is a safe and appropriate treatment option for you.

Overall, Risankizumab-Rzaa is a valuable treatment option for individuals with moderate to severe plaque psoriasis. If you have been struggling to manage your psoriasis symptoms, talk to your healthcare provider to see if Risankizumab-Rzaa may be right for you.